We are live on
!
Find out more
H
HoyleCohen Portfolio holdings
AUM
$1.32B
1-Year Est. Return
27.05%
This Fund
S&P 500
This Quarter
Est. Return
+10.28%
1 Year Est. Return
+27.05%
3 Year Est. Return
+46.07%
5 Year Est. Return
+145.61%
10 Year Est. Return
–
AUM
$629M
AUM Growth
+$43M
(+7.3%)
Cap. Flow
-$9.68M
Cap. Flow
% of AUM
-1.54%
Top 10 Holdings %
Top 10 Hldgs %
31.07%
Holding
200
New
10
Increased
51
Reduced
94
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.07M |
| 2 |
ProShares UltraShort Dow 30
DXD
|
+$536K |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$511K |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$298K |
| 5 |
American Tower
AMT
|
+$228K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$3.65M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.43M |
| 3 |
FOCS
Focus Financial Partners Inc. Class A
FOCS
|
+$639K |
| 4 |
ProShares UltraShort S&P500
SDS
|
+$590K |
| 5 |
Apple
AAPL
|
+$514K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.18% |
| 2 | Financials | 12.6% |
| 3 | Communication Services | 9.36% |
| 4 | Healthcare | 8.82% |
| 5 | Industrials | 8.46% |
Similar funds
PRIG
HIG
PO
BPCA
GP
AT
KI
CDH
HoyleCohen's Q4 2019 Portfolio in Review
As of Q4 2019, HoyleCohen held 200 positions worth $629M, up 7.3% from $586M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
HoyleCohen's Q4 2019 filing shows 10 new, 51 increased, 94 reduced and 5 closed positions. Its largest new stake was ProShares UltraShort Dow 30: 4,400 shares worth $496K. The largest sale was Celgene Corp, an estimated $3.65M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
- HoyleCohen's largest Q4 2019 buy was ProShares UltraShort Dow 30: 4,400 shares worth $496K.
- HoyleCohen added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.07M increase.
- HoyleCohen's biggest Q4 2019 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $1.43M.
- HoyleCohen fully exited Celgene Corp in Q4 2019, selling an estimated $3.65M.
- HoyleCohen's ten largest holdings make up 31% of its $629M portfolio in Q4 2019.
- HoyleCohen opened 10 new positions and closed 5 in Q4 2019.
- HoyleCohen's portfolio value rose 7.3% quarter-over-quarter to $629M.
Based on HoyleCohen's 13F filing for Q4 2019, filed 10 Feb 2020.